1
|
Noto T, Zhou G, Schuele S, Templer J, Zelano C. Automated analysis of breathing waveforms using BreathMetrics: a respiratory signal processing toolbox. Chem Senses 2018; 43:583-597. [PMID: 29985980 PMCID: PMC6150778 DOI: 10.1093/chemse/bjy045] [Citation(s) in RCA: 32] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
Nasal inhalation is the basis of olfactory perception and drives neural activity in olfactory and limbic brain regions. Therefore, our ability to investigate the neural underpinnings of olfaction and respiration can only be as good as our ability to characterize features of respiratory behavior. However, recordings of natural breathing are inherently nonstationary, nonsinusoidal, and idiosyncratic making feature extraction difficult to automate. The absence of a freely available computational tool for characterizing respiratory behavior is a hindrance to many facets of olfactory and respiratory neuroscience. To solve this problem, we developed BreathMetrics, an open-source tool that automatically extracts the full set of features embedded in human nasal airflow recordings. Here, we rigorously validate BreathMetrics' feature estimation accuracy on multiple nasal airflow datasets, intracranial electrophysiological recordings of human olfactory cortex, and computational simulations of breathing signals. We hope this tool will allow researchers to ask new questions about how respiration relates to body, brain, and behavior.
Collapse
Affiliation(s)
- Torben Noto
- Department of Neurology, Northwestern University Feinberg School of Medicine, Ward, Chicago, IL, USA
| | - Guangyu Zhou
- Department of Neurology, Northwestern University Feinberg School of Medicine, Ward, Chicago, IL, USA
| | - Stephan Schuele
- Department of Neurology, Northwestern University Feinberg School of Medicine, Ward, Chicago, IL, USA
| | - Jessica Templer
- Department of Neurology, Northwestern University Feinberg School of Medicine, Ward, Chicago, IL, USA
| | - Christina Zelano
- Department of Neurology, Northwestern University Feinberg School of Medicine, Ward, Chicago, IL, USA
| |
Collapse
|
2
|
Bollu PC. Sleep and Parkinson Disease. MISSOURI MEDICINE 2017; 114:381-386. [PMID: 30228640 PMCID: PMC6140184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Sleep disorders are prevalent in Parkinson disease (PD), a disease with well recognized motor dysfunction. Sleep related problems received little attention until the last three decades. Sleep disorders seen in PD patients include insomnia, excessive sleepiness, restless legs syndrome, REM sleep behavior disorder. Some of these can have significant impact and lower the quality of life in these patients. An understanding of sleep issues in PD can help identify them early and result in optimal management.
Collapse
Affiliation(s)
- Pradeep C. Bollu
- Pradeep C. Bollu, MD, MSMA member since 2003, in the Department of Neurology, University of Missouri School of Medicine
| |
Collapse
|
3
|
Abstract
Breathing requires complex interactions of the central and peripheral nervous systems with the respiratory system. It involves cortical (volitional) as well as subcortical (automatic) output. Cortical output is mainly through the corticospinal tract, whereas the brainstem sends signals via the reticulospinal tract. Groups of nuclei in the brainstem (pneumotaxic center, dorsal and ventral respiratory group), situated in the pons and medulla, function as rhythm generators. Some of these nuclei have intrinsic pacemaker activity; however, their output is affected extensively by various chemical (through aortic and carotid bodies), mechanical (stretch reflexes), and neural feedbacks from the peripheral nervous system involving cranial nerves V, VII, IX, X, and XI. Brainstem nuclei also have central chemoreceptors that detect changes in serum carbon dioxide and pH. Various neurologic disorders such as stroke or neurodegenerative diseases (Parkinson's disease, multiple system atrophy) can adversely affect respiration and may even be the first sign of disease onset. Clinicians should have a better understanding of this complex but important physiological process to better appreciate pathologies affecting it. Future research is needed to enhance our understanding of this intricate process.
Collapse
Affiliation(s)
- Mian Zain Urfy
- Department of Neurology, Baylor College of Medicine, Houston, TX, USA
| | - Jose I Suarez
- Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
| |
Collapse
|
4
|
|
5
|
Sleep apnea in Parkinson’s disease: When is it significant? Sleep Med 2010; 11:233-5. [DOI: 10.1016/j.sleep.2009.11.008] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2009] [Accepted: 11/05/2009] [Indexed: 11/24/2022]
|
6
|
Abstract
BACKGROUND Control of ventilation depends on a brainstem neuronal network that controls activity of the motor neurons innervating the respiratory muscles. This network includes the pontine respiratory group and the dorsal and ventral respiratory groups in the medulla. Neurologic disorders affecting these areas or the respiratory motor unit may lead to abnormal breathing. REVIEW SUMMARY The brainstem respiratory network contains neurons critical for respiratory rhythmogenesis; this network receives inputs from peripheral and central chemoreceptors sensitive to levels of carbon dioxide (PaCO2) and oxygen (PaO2) and from forebrain structures that control respiration as part of integrated behaviors such as speech or exercise. Manifestations associated with disorders of this network include sleep apnea and dysrhythmic breathing frequently associated with disturbances of cardiovagal and sympathetic vasomotor control. Common disorders associated with impaired cardiorespiratory control include brainstem stroke or compression, syringobulbia, Chiari malformation, high cervical spinal cord injuries, and multiple system atrophy. By far, neuromuscular disorders are the more common neurologic conditions leading to respiratory failure. CONCLUSIONS Respiratory dysfunction constitute an early and relatively major manifestation of several neurologic disorders and may be due to an abnormal breathing pattern generation due to involvement of the cardiorespiratory network or more frequently to respiratory muscle weakness.
Collapse
|
7
|
Trenkwalder C, Högl B. Sleep in Parkinson syndromes. HANDBOOK OF CLINICAL NEUROLOGY 2007; 83:365-76. [PMID: 18808922 DOI: 10.1016/s0072-9752(07)83015-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
8
|
Abstract
Parkinson's disease is primarily considered to be a movement disorder and is defined by its motor signs. Yet, the behavioral manifestations of the disease are often more debilitating than its motor complications. This review will focus on the non-motor aspects of Parkinson's disease, including mood, psychosis, cognitive, sleep, fatigue, apathy, delirium, and repetitive disorders, that may occur. The phenomenology, pathology, and treatment of the behavioral symptoms of Parkinson's disease will be discussed.
Collapse
Affiliation(s)
- Leora L Borek
- Department of Geriatric Psychiatry, Brown University School of Medicine, Providence, RI, USA.
| | | | | |
Collapse
|
9
|
Abstract
The perioperative management of patients who have PD requires knowledge of the potential complications of various types of surgery. Neurologists should be able to balance patient comfort against the potential complications of antiparkinsonian therapy. The authors believe that the approach outlined in the Appendix increases patient comfort, facilitates nursing care, and can potentially reduce some of the complications seen in the postoperative period.
Collapse
Affiliation(s)
- Néstor Gálvez-Jiménez
- Department of Neurology, The Cleveland Clinic-Florida, Weston (Fort Lauderdale), FL 3331, USA.
| | | |
Collapse
|
10
|
Abstract
Sleep problems are an under-emphasised cause of disability in Parkinson's disease (PD) and may be seen independently of PD, associated with primary PD pathology, or as a result of antiparkinsonian medications. Common sleep disorders include excessive daytime sleepiness, rapid eye movement (REM) sleep behaviour disorder, night-time wakefulness and restless legs syndrome. A number of strategies may be used to improve sleep cycle disturbances, and often these interventions do not require pharmacological manipulation. Restoring traditional mealtimes and scheduling activities during predicted periods of sleepiness may help alleviate daytime somnolence; the use of controlled-release levodopa preparations or administration of a catechol-O-methyl transferase (COMT) inhibitor with levodopa at bedtime may reduce periods of night-time wakefulness. Administration of clonazepam at bedtime may assist with REM sleep behaviour disorder but, because this agent can result in daytime somnolence, experimentation with dosage times is recommended. Sleep attacks are described as a sudden, unavoidable transition from wakefulness to sleep and, although rare, have been described with pramipexole, ropinirole and other dopamine agonists. Although the condition has yet to be recognised by the International Association of Sleep Disorders, patients with PD who report rapid sleep onset should be evaluated for the possibility of sleep attacks. If sleep attacks are suspected, it is reasonable to strongly caution patients regarding potentially risk-associated activities such as driving, and to consider careful withdrawal of dopaminergic therapy.
Collapse
Affiliation(s)
- Mark Stacy
- Muhammad Ali Parkinson Research Center, Barrow Neurological Institute, Phoenix, Arizona 85013, USA.
| |
Collapse
|
11
|
Abstract
Sleep disorders are common in Parkinson's disease (PD), as almost two thirds of PD patients report them. From a clinical point of view, they can be classified into disorders of initiation and maintenance of sleep (DIMS), parasomnias, and excessive daytime sleepiness (EDS). Among the causes of DIMS are degenerative changes in the CNS affecting centers for sleep regulation, persistence into the night of daytime PD-related symptoms, concomitant medical or psychiatric disease, disruption of circadian rhythms, and effects of dopaminergic (and other) medication on sleep regulation. Parasomnias might further contribute to sleep disturbance, as they can be accompanied by motor desinhibition during REM sleep. Parasomnias can precede by several years the presence of daytime PD symptoms. EDS has been over the last years the focus of attention for both sleep and movement disorders specialists, due to the fact that it might predispose to traffic accidents. However, the so-called "sleep attacks" never occur without preexisting somnolence. Thus, a careful sleep history can be helpful to determine which patients are exposed to suffer them. Although EDS was initially attributed to the effects of dopaminergic medication, it seems likely that several disease-related factors might also play an important role. An adequate education of the PD patients in sleep hygiene measures and a skilled use of the medication seem necessary to prevent sleep disturbance.
Collapse
|
12
|
Högl B, Seppi K, Brandauer E, Glatzl S, Frauscher B, Niedermüller U, Wenning G, Poewe W. Increased daytime sleepiness in Parkinson's disease: a questionnaire survey. Mov Disord 2003; 18:319-323. [PMID: 12621636 DOI: 10.1002/mds.10365] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
We evaluated the frequency and severity of excessive daytime sleepiness in an outpatient population with Parkinson's disease in comparison to age-matched controls and examined its relationship with antiparkinsonian drug therapy and sleep history. Increased daytime sleepiness and involuntary sleep episodes have been described in Parkinson's disease, but the etiology is not completely understood. The Epworth Sleepiness Scale (ESS), a validated questionnaire for daytime sleepiness, was prospectively administered to 99 consecutive outpatients with Parkinson's disease and 44 age-matched controls. In addition, a short sleep-screening questionnaire was used. The ESS revealed significantly increased daytime sleepiness in PD patients compared to controls (7.5 +/- 4.6 vs. 5.8 +/- 3.0, P = 0.013). The ESS score was abnormally high (10 or more) in 33 % of PD patients and 11.4% of controls (P = 0.001). ESS was not different between PD patients on levodopa monotherapy and those on levodopa and dopamine agonists, or between patients taking ergoline or non-ergoline dopamine agonists. In PD patients and in controls, sleepiness was significantly associated with reported heavy snoring. Increased daytime sleepiness is more frequent in patients with PD than in elderly controls. Similar to controls, increased daytime sleepiness in PD patients is correlated with heavy snoring.
Collapse
Affiliation(s)
- Birgit Högl
- Department of Neurology, University of Innsbruck, Austria
| | - Klaus Seppi
- Department of Neurology, University of Innsbruck, Austria
| | | | - Susanne Glatzl
- Department of Neurology, University of Innsbruck, Austria
| | | | | | - Gregor Wenning
- Department of Neurology, University of Innsbruck, Austria
| | - Werner Poewe
- Department of Neurology, University of Innsbruck, Austria
| |
Collapse
|
13
|
A review of normal sleep and its disturbances in Parkinson’s disease. Parkinsonism Relat Disord 1999; 5:1-17. [DOI: 10.1016/s1353-8020(99)00011-5] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/1998] [Revised: 02/10/1999] [Accepted: 02/10/1999] [Indexed: 11/21/2022]
|
14
|
Abstract
Although the clinical manifestations of PD remain similar to those described by Parkinson in the nineteenth century, knowledge of associated findings has increased dramatically. The ability to characterize the myriad of findings associated with PD enables clinicians to care better for patients with PD. Knowledge of the associated symptoms as well as the cardinal manifestations allows clinicians to target treatment to specific symptoms and thereby improve the quality of life of those affected with PD.
Collapse
Affiliation(s)
- A Colcher
- Department of Neurology, Pennsylvania Hospital, University of Pennsylvania School of Medicine, Philadelphia, USA
| | | |
Collapse
|
15
|
Abstract
This article summarizes sleep disturbances in a variety of neuro-degenerative diseases, including Parkinson's disease, multiple system atrophy, and amyotrophic lateral sclerosis. Sleep complaints in these conditions include insomnia, hypersomnia, abnormal motor activity and behavior during sleep, sleep-related breathing problems, and circadian rhythm sleep disturbances. Clinical examination followed in selected cases by polysomnographic, multiple sleep latency, and other laboratory tests is essential for correct diagnosis and treatment of these sleep disturbances.
Collapse
Affiliation(s)
- S Chokroverty
- Department of Neurology, St. Vincent's Hospital and Medical Center, New York, New York, USA
| |
Collapse
|
16
|
Abstract
Two major sources of dissatisfaction with the quality of life among Parkinsonian patients are the "locomotor disability" and the "nature of their sleep". The main focus of research was directed towards the locomotor disability, but in the last two decades some progress has been made towards the understanding of sleep in PD patients. Sleep in Parkinson's disease is light and fragmented due to an increased skeletal muscle activity, disturbed breathing, impaired biological rhythm and REM-nonREM variations of the dopaminergic receptor sensitivity.
Collapse
Affiliation(s)
- J J Askenasy
- Sleep Research Institute, Sheba Medical Center, Tel-Aviv University, Israel
| |
Collapse
|
17
|
Aldrich MS. Neurologie Aspects of Sleep Apnea and Related Respiratory Disturbances. Otolaryngol Clin North Am 1990. [DOI: 10.1016/s0030-6665(20)31251-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|